Cell-mediated immunity to tumor-associated antigens is a better predictor of survival in early stage breast cancer than stage, grade or lymph node status (Q74126218)
Jump to navigation
Jump to search
scientific article published on 01 April 2000
Language | Label | Description | Also known as |
---|---|---|---|
English | Cell-mediated immunity to tumor-associated antigens is a better predictor of survival in early stage breast cancer than stage, grade or lymph node status |
scientific article published on 01 April 2000 |
Statements
Cell-mediated immunity to tumor-associated antigens is a better predictor of survival in early stage breast cancer than stage, grade or lymph node status (English)
J L Mccoy
R Rucker